DDI-DrugBank.d637.s0 >> Use with Other Central Nervous System Depressants: The depressant effects of morphine are potentiated by the presence of other CNS depressants such as alcohol, sedatives, antihistaminics, or psychotropic drugs. >> 15-48,77-84,127-141,151-157,160-168,171-185,191-208
DDI-DrugBank.d637.s1 >> Use of neuroleptics in conjunction with oral morphine may increase the risk of respiratory depression, hypotension and profound sedation or coma. >> 7-18,45-52
DDI-DrugBank.d637.s2 >> Interaction with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (i.e., pentazocine, nalbuphine, butorphanol, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic. >> 17-58,61-89,98-108,111-120,123-133,139-151,261-284
DDI-DrugBank.d637.s3 >> In these patients, the mixed agonist/antagonist may alter the analgesic effect or may precipitate withdrawal symptoms.
